Mitral Valve Stenosis – Causes, Symptoms & Treatment
Mitral valve stenosis is a narrowing of the mitral valve in the heart that restricts blood flow from the left atrium into the left ventricle.
Things worth knowing about "Mitral Valve Stenosis"
Mitral valve stenosis is a narrowing of the mitral valve in the heart that restricts blood flow from the left atrium into the left ventricle.
What Is Mitral Valve Stenosis?
Mitral valve stenosis (also known as mitral stenosis) is a heart valve disease in which the mitral valve – the valve between the left atrium and the left ventricle – becomes abnormally narrowed. Under normal conditions, this valve opens widely to allow oxygen-rich blood from the lungs to flow freely into the left ventricle. When stenosis is present, this opening is chronically restricted, forcing the heart to work harder and causing blood to back up into the left atrium and lungs.
Causes
The most common cause of mitral valve stenosis worldwide is rheumatic fever, an inflammatory condition that can develop as a complication of untreated streptococcal throat infection. This causes the valve leaflets to fuse and scar, leading to permanent narrowing. Other possible causes include:
- Congenital malformations of the mitral valve
- Calcification of the valve structures in older age
- Rare inflammatory conditions such as systemic lupus erythematosus
- Radiation therapy to the chest area (as a late complication)
Symptoms
In the early stages, mitral valve stenosis often causes no symptoms. As the narrowing progresses, the following symptoms may develop:
- Exertional dyspnea: Shortness of breath during physical activity, and later at rest
- Palpitations or irregular heartbeat (often due to atrial fibrillation)
- Cough, sometimes with blood-tinged sputum (hemoptysis)
- Fatigue and reduced exercise tolerance
- Fluid retention (edema) in the legs or lungs
- Dizziness or fainting episodes during exertion
Diagnosis
Mitral valve stenosis is diagnosed using several investigations:
- Physical examination: A physician can detect a characteristic mitral opening snap and a diastolic heart murmur using a stethoscope.
- Echocardiography (cardiac ultrasound): The primary investigation for assessing valve opening area, severity, and cardiac function.
- Electrocardiogram (ECG): May reveal signs of atrial fibrillation or left atrial enlargement.
- Chest X-ray: Can show an enlarged left atrium or pulmonary congestion.
- Cardiac catheterization: Used when precise pressure measurements or coronary artery assessment is needed.
Severity Grading
Mitral valve stenosis is classified by valve opening area:
- Mild: Opening area greater than 1.5 cm²
- Moderate: Opening area 1.0–1.5 cm²
- Severe: Opening area less than 1.0 cm²
Treatment
Medical Therapy
Medical treatment cannot eliminate the stenosis itself but can relieve symptoms and prevent complications. Commonly used medications include:
- Diuretics to manage fluid retention and congestion symptoms
- Beta-blockers or calcium channel blockers for heart rate control
- Anticoagulants (blood thinners) in patients with atrial fibrillation to prevent stroke
- Antibiotic prophylaxis in patients at risk of rheumatic fever recurrence
Interventional and Surgical Treatment
For moderate to severe stenosis with symptoms, the following procedures are considered:
- Percutaneous balloon mitral valvuloplasty (PBMV): A catheter-based procedure in which a balloon is inserted into the narrowed valve and inflated to widen it. This is the preferred treatment when valve anatomy is suitable.
- Surgical mitral valve repair: Open-heart surgical correction of the valve.
- Mitral valve replacement: Replacement of the diseased valve with a mechanical or biological prosthesis when repair is not feasible.
Prognosis and Outlook
Mitral valve stenosis typically progresses slowly, and many patients remain symptom-free for years. Without treatment, serious complications can arise, including heart failure, atrial fibrillation, stroke from blood clots, or pulmonary hypertension (elevated blood pressure in the lungs). After successful intervention or surgery, symptoms improve significantly in most cases.
References
- Vahanian A. et al. – 2021 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal, 2022; 43(7): 561–632.
- Carabello B.A. – Mitral Stenosis. In: Zipes D.P. et al. (eds.), Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th edition, Elsevier, 2022.
- World Health Organization (WHO) – Rheumatic Heart Disease. Fact Sheet. Available at: https://www.who.int (accessed 2024).
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Mitral Valve Stenosis-en